Tampa, FL (Feb. 10, 2011) — Preladenant, a non-dopaminergic medication, reduces off time in patients with Parkinson’s disease receiving standard dopamine therapy, an international study led by the University of South Florida found.
Results of th…
In a sub-analysis of data from an earlier trial comparing the ability of three agents used to restore blood flow to patients soon after heart attacks, researchers have found that drugs used to prevent blood coagulation appear to have different effects in heart patients with diabetes. These findings, coupled with an assessment of ease of administration and cost compared to other drugs, has lead researchers to recommend the drug enoxaparin, which is a low-molecular weight heparin, for acute heart attack patients with diabetes.